Por: RTTNews Health November 27, 2023
Neumora Therapeutics, Inc. () announced the initiation of a Phase 1 single ascending dose / multiple ascending dose study evaluating NMRA-266 in healthy adult participants. The company believes that as a selective M4 receptor-positive allosteric modulator, NMRA-266 has the potential to deliver antipsychotic efficacy, while minimizing side effects. NMRA-266 is an investigational positive allosteric modulator of the M4 muscarinic receptor subtype,... + full article
RTTNews USA Health November 27, 2023
Biopharmaceutical company Outlook Therapeutics, Inc. () announced Monday the receipt of the official minutes from the Type A meeting with the U.S. Food and Drug Administration (FDA) held in October 2023.The type A meeting was regarding the Complete Response Letter (CRL) dated... + más
Protalix Resubmits To FDA The BLA For Pegunigalsidase Alfa For Treatment Of Fabry Disease | RTTNews
Sarepta Therapeutics Updates Of BLA For Sarepta's Duchenne Muscular Dystrophy Drug Candidate | RTTNews
ABC News USA Politics October 12, 2023
Hamas' militants launched a over the weekend, killing at least 1,200 people, and Israel , with President Joe Biden and other top administration officials pledging aid to the Israelis.That underlines the U.S.'s continued support for Israel. Gallup polling that adults... + más
NFL Playoff Scenarios | ABC News
Le Krewe du Roi celebrates the state at 58th annual Mardi Gras Ball | The Advocate
RTTNews USA Business September 11, 2023
Biopharmaceutical company Neumora Therapeutics, Inc. revealed Monday that it will offer 14.71 million shares of its common stock in an initial public offering and expects the IPO price to be between $16.00 and $18.00 per share, according to an amended Form S-1 filing with the... + más
Watertown biotech Neumora’s depression treatment shows promise in trial | The Boston Globe
The Boston Globe USA Business July 21, 2023
Neumora, a privately held biotech company based in Watertown, is moving into the final phase of testing with a novel treatment for depression that showed promise in a mid-stage trial.The drug, a daily pill called navacaprant, led to statistically significant improvements over... + más
Not far from Kendall Square, Watertown emerges as a biotech hub | The Boston Globe
Watertown has been a city for decades. Now, it’s acting like one. | The Boston Globe
Orlando Sentinel USA Entertainment April 17, 2023
In the first week of a new TV season, football was the top draw in prime time and a huge driver of viewers. The NFL provided the most-watched telecast on Sunday and Thursday. CBS’ NFL coverage on Sunday – which started outside prime time -- averaged 20.7 million viewers in... + más
Did Martha Washington really name a cat after Alexander Hamilton? | The Boston Globe
'Frustration' fuels Broncos' sideline blowup in loss | ESPN
RTTNews USA Health January 18, 2023
This commercial-stage biotechnology company developing next-generation, targeted antibody drug conjugates is aiming to achieve double-digit year-over-year revenue growth for its lead drug.The company we are profiling today is ADC Therapeutics SA () and the drug in focus is... + más
Nkarta | RTTNews
Chicago White Sox pitcher Liam Hendriks says he will undergo cancer treatment after being diagnosed with non-Hodgkin's lymphoma | CBS News
Fox News USA Politics November 12, 2022
The results of about two dozen congressional races across the country are still outstanding and all Republicans need to successfully flip the chamber (and retiring are seven of them.So far, after Tuesday’s midterm elections results, Republicans have secured 211 seats of the... + más
A simple guide to midterm elections, how they affect the presidency, and more | Fox News
Lake Charles carbon capture group partners with Swiss firm for carbon dioxide removal | The Advocate
About iurex | Privacy Policy | Disclaimer |